Maball Rituximab Injection

About Maball Rituximab Injection

Maball Rituximab Injection is a monoclonal antibody used in the treatment of various autoimmune disorders and certain types of cancers. It works by specifically targeting the CD20 antigen present on B-lymphocytes, leading to the destruction of abnormal or overactive B cells. This helps in controlling disease progression and improving patient outcomes.

• Non-Hodgkins Lymphoma

• Chronic Lymphocytic Leukemia (CLL)

• Rheumatoid Arthritis

• Other CD20-positive B-cell disorders (as prescribed by a physician)

• Targeted monoclonal antibody therapy

• Effective in oncology and autoimmune indications

• Helps reduce disease progression

• Administered under medical supervision

• Trusted choice for hospital and clinical use

• Store between 2C to 8C

• Do not freeze

• Protect from light

• To be administered only by qualified healthcare professionals

• Dosage and treatment duration as per doctors advice

• Monitor patients for infusion-related reactions